Protocol No
NEURO-GENENTECH-CIELO
Phase
III
Summary
This project is being done to assess the effects, good or bad, of satralizumab in patients with autoimmune encephalitis.
Description
Satralizumab in NMDAR or LGI1 Enchephalitis
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
ClinicalTrials.gov